Continuous twin-screw wet granulation without adding granulation liquid.

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Dániel Fekete, Richárd Ferdinánd Tóth, Zsombor Kristóf Nagy, Thorsten Cech, Lukas Ries, Edina Szabó
{"title":"Continuous twin-screw wet granulation without adding granulation liquid.","authors":"Dániel Fekete, Richárd Ferdinánd Tóth, Zsombor Kristóf Nagy, Thorsten Cech, Lukas Ries, Edina Szabó","doi":"10.1016/j.ejps.2025.107295","DOIUrl":null,"url":null,"abstract":"<p><p>Granulation is a major focus of pharmaceutical R&D, as a key step in the development of solid pharmaceuticals. In parallel, the spread of continuous integrated powder-to-tablet production lines is also underway. In this research, a new wet granulation method has been investigated in terms of operation and scalability in a fully continuous powder-to-tablet line. The new wet granulation technique requires no addition of granulation liquid to the powder blend; thus, requires only minimal cooling after granulation, providing a more energy-efficient continuous integrated system for the pharmaceutical industry. This can be achieved by adding an excipient with a monograph and a high daily intake, potassium sodium tartrate tetrahydrate (PST), to the starting powder mixture. PST contains water of crystallization which is released by temperature, forming an in-situ granulation liquid during the process. This wet granulation-based technology produced granules with excellent flowability and immediate-release tablets exceeding 100 N breaking force and 1.5 MPa tensile strength. The continuous setup enabled easy scale-up from 0.5 to 10 kg/h using the same equipment and process parameters.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107295"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejps.2025.107295","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Granulation is a major focus of pharmaceutical R&D, as a key step in the development of solid pharmaceuticals. In parallel, the spread of continuous integrated powder-to-tablet production lines is also underway. In this research, a new wet granulation method has been investigated in terms of operation and scalability in a fully continuous powder-to-tablet line. The new wet granulation technique requires no addition of granulation liquid to the powder blend; thus, requires only minimal cooling after granulation, providing a more energy-efficient continuous integrated system for the pharmaceutical industry. This can be achieved by adding an excipient with a monograph and a high daily intake, potassium sodium tartrate tetrahydrate (PST), to the starting powder mixture. PST contains water of crystallization which is released by temperature, forming an in-situ granulation liquid during the process. This wet granulation-based technology produced granules with excellent flowability and immediate-release tablets exceeding 100 N breaking force and 1.5 MPa tensile strength. The continuous setup enabled easy scale-up from 0.5 to 10 kg/h using the same equipment and process parameters.

连续双螺杆湿式造粒,无需添加造粒液。
造粒作为固体药物开发的关键步骤,是制药研发的主要焦点。与此同时,连续一体化粉末到片剂生产线也在推广中。在本研究中,研究了一种新的湿造粒方法在全连续粉制片生产线上的操作和可扩展性。新的湿法造粒技术不需要在粉末混合物中添加造粒液;因此,造粒后只需要最小的冷却,为制药工业提供更节能的连续集成系统。这可以通过在起始粉末混合物中添加一种具有专一性和高日摄入量的赋形剂,四水合物酒石酸钾钠(PST)来实现。PST含有结晶水,在温度作用下释放出来,在过程中形成原位造粒液。以湿造粒技术为基础,生产出流动性优异的颗粒和破断力超过100 N、抗拉强度超过1.5 MPa的速释片剂。使用相同的设备和工艺参数,连续设置可以轻松地从0.5 kg/h扩展到10 kg/h。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.60
自引率
2.20%
发文量
248
审稿时长
50 days
期刊介绍: The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信